Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Drug Development Consulting BidCo ApS
APS
Active
Advertising protection
CVR 42287067
Smedeland 36, 2600
Glostrup
Business and other management consultancy activities
·
NACE 7020
Est. 2021 · 5 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
Drug Development Consulting BidCo ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
RH
René Holmen Pedersen
Management
Management
2023
Former (3)
JM
Jasper Michiel van Gorp
Management
Management
2021 – 2021
RK
Rasmus Koch Nelund
Management
Management
2023 – 2025
AM
Alejandra Maria Cristina Bonifacini Mørk
Management
Management
2021 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
RN
Rafael Natanek
Board of Directors
Board of Directors
2023
NP
Niels Peder Nielsen
Chairman
Chairman
2023
AM
Alejandra Maria Cristina Bonifacini Mørk
Board of Directors
Board of Directors
2023
RK
Redmar Koene
Board of Directors
Board of Directors
2021
Former (1)
MK
Mette Kirstine Agger
Board of Directors
Board of Directors
2021 – 2024
Shareholders
As of last annual report
Drug Development Consulting Holding ApS — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Drug Development Consulting Holding ApS
Company
100%
100%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Drug Development Consulting BidCo ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network